215 related articles for article (PubMed ID: 28696419)
21. A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia.
Lopez-Lopez E; Martin-Guerrero I; Ballesteros J; Garcia-Orad A
Pharmacogenomics J; 2013 Dec; 13(6):498-506. PubMed ID: 23089671
[TBL] [Abstract][Full Text] [Related]
22. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
[TBL] [Abstract][Full Text] [Related]
23. Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients.
Saleh MM; Irshaid YM; Mustafa KN
Int J Clin Pharmacol Ther; 2015 Feb; 53(2):154-62. PubMed ID: 25492850
[TBL] [Abstract][Full Text] [Related]
24. MTHFR C677T, A1298C and MS A2756G Gene Polymorphisms and Male Infertility Risk in a Chinese Population: A Meta-Analysis.
Ren Z; Ren P; Yang B; Fang K; Ren S; Liao J; Liu S; Liu L; Peng Z; Dong Q
PLoS One; 2017; 12(1):e0169789. PubMed ID: 28081209
[TBL] [Abstract][Full Text] [Related]
25. No evidence of association of methylenetetrahydrofolate reductase polymorphism with occurrence of second neoplasms after treatment of childhood leukemia.
Jazbec J; Kitanovski L; Aplenc R; Debeljak M; Dolzan V
Leuk Lymphoma; 2005 Jun; 46(6):893-7. PubMed ID: 16019535
[TBL] [Abstract][Full Text] [Related]
26. MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms.
Owen SA; Lunt M; Bowes J; Hider SL; Bruce IN; Thomson W; Barton A
Pharmacogenomics J; 2013 Apr; 13(2):137-47. PubMed ID: 21931346
[TBL] [Abstract][Full Text] [Related]
27. Association of Methylenetetrahydrofolate Reductase C677T and A1298C Gene Polymorphisms With Recurrent Pregnancy Loss in Syrian Women.
Al-Achkar W; Wafa A; Ammar S; Moassass F; Jarjour RA
Reprod Sci; 2017 Sep; 24(9):1275-1279. PubMed ID: 28814189
[TBL] [Abstract][Full Text] [Related]
28. Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis.
Liu B; Liu G; Liu B; Guo Y; Peng N; Li T
World J Surg Oncol; 2024 Jan; 22(1):19. PubMed ID: 38212758
[TBL] [Abstract][Full Text] [Related]
29. Common Methylenetetrahydrofolate Reductase Polymorphisms (A1298C & C677T) in Ectopic Trophoblasts and Methotrexate Treatment Failure in Tubal Pregnancies.
Zafer E; Kahraman Cetin N; Turan OD; Kardelen E; Kurt Omurlu I; Yuksel H
Ginekol Pol; 2018; 89(10):536-540. PubMed ID: 30393840
[TBL] [Abstract][Full Text] [Related]
30. Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma.
Zhang Y; Chen GQ; Ji Y; Huang B; Shen WS; Deng LC; Xi L; Cao XM
Mol Biol Rep; 2012 May; 39(5):6203-11. PubMed ID: 22215214
[TBL] [Abstract][Full Text] [Related]
31. Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for preeclampsia: a meta-analysis.
Wu X; Yang K; Tang X; Sa Y; Zhou R; Liu J; Luo Y; Tang W
J Assist Reprod Genet; 2015 May; 32(5):797-805. PubMed ID: 25758986
[TBL] [Abstract][Full Text] [Related]
32. Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.
El-Khodary NM; El-Haggar SM; Eid MA; Ebeid EN
Med Oncol; 2012 Sep; 29(3):2053-62. PubMed ID: 21644011
[TBL] [Abstract][Full Text] [Related]
33. Association between MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: a meta-analysis based on 51 case-control studies.
Li SY; Ye JY; Liang EY; Zhou LX; Yang M
Med Sci Monit; 2015 Mar; 21():740-8. PubMed ID: 25761797
[TBL] [Abstract][Full Text] [Related]
34. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
35. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
[TBL] [Abstract][Full Text] [Related]
36. Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity.
Tan Y; Kong Q; Li X; Tang Y; Mai H; Zhen Z; Zhou D; Chen H
Transl Pediatr; 2023 Jan; 12(1):31-45. PubMed ID: 36798930
[TBL] [Abstract][Full Text] [Related]
37. MTHFR polymorphisms and ovarian cancer risk: a meta-analysis.
Liu L; Liao SG; Wang YJ
Mol Biol Rep; 2012 Nov; 39(11):9863-8. PubMed ID: 22810649
[TBL] [Abstract][Full Text] [Related]
38. Significant association between MTHFR C677T polymorphism and thyroid cancer risk: evidence from a meta-analysis.
Chen Y; Wang B; Yan S; Wang YG
Genet Test Mol Biomarkers; 2014 Oct; 18(10):695-702. PubMed ID: 25007377
[TBL] [Abstract][Full Text] [Related]
39. Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia.
Chae H; Kim M; Choi SH; Kim SK; Lee JW; Chung NG; Cho B; Kim Y
J Chemother; 2020 Sep; 32(5):251-259. PubMed ID: 32431230
[TBL] [Abstract][Full Text] [Related]
40. Associations of C677T polymorphism in methylenetetrahydrofolate reductase (MTHFR) gene with male infertility risk: A meta-analysis.
Hong HH; Hu Y; Yu XQ; Zhou L; Lv MQ; Sun Y; Ren WJ; Zhou DX
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():101-109. PubMed ID: 28363185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
